Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report) shares hit a new 52-week high during trading on Monday . The company traded as high as $46.80 and last traded at $46.71, with a volume of 45438 shares traded. The stock had previously closed at $46.04.
Analyst Ratings Changes
Separately, Royal Bank of Canada lowered Sandoz Group from a “moderate buy” rating to a “hold” rating in a research report on Monday, September 16th.
Read Our Latest Stock Analysis on Sandoz Group
Sandoz Group Price Performance
About Sandoz Group
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Featured Articles
- Five stocks we like better than Sandoz Group
- Bank Stocks – Best Bank Stocks to Invest In
- Intel: Is Now the Time to Be Brave?Â
- When to Sell a Stock for Profit or Loss
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- How to Find Undervalued Stocks
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
